Literature DB >> 16529967

[Ovarian cancers and CA 125 in 2006].

E Lambaudie1, P Collinet, D Vinatier.   

Abstract

The authors propose to report progress on the use of the CA 125 serum assay. It affects three situations: screening, diagnosis and the follow-up of the patients dealt with ovarian tumour either of benign or malignant nature. For each situation the interest and the relevance of CA 125 assay will be approached.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16529967     DOI: 10.1016/j.gyobfe.2006.01.026

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil        ISSN: 1297-9589


  1 in total

1.  The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling.

Authors:  Rémi Longuespée; Charlotte Boyon; Céline Castellier; Amélie Jacquet; Annie Desmons; Olivier Kerdraon; Denis Vinatier; Isabelle Fournier; Robert Day; Michel Salzet
Journal:  Histochem Cell Biol       Date:  2012-04-25       Impact factor: 4.304

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.